Using PSA to predict extra capsular disease in T1c prostate cancer

被引：0
|
作者：
Crozier, J. [1 ,2 ]
Blecher, G. [1 ]
Papa, N. N. [2 ]
Evans, S. [3 ]
Millar, J. [3 ]
Travis, D. [1 ]
机构：
[1] Western Hlth, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Victorian Prostate Canc Registry, Melbourne, Vic, Australia
来源：
BJU INTERNATIONAL | 2016年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
151
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [21] Prostate specific antigen detected prostate cancer (clinical stage T1c): An interim analysis
    Lerner, SE
    Seay, TM
    Blute, ML
    Bergstralh, EJ
    Barrett, D
    Zincke, H
    JOURNAL OF UROLOGY, 1996, 155 (03): : 821 - 826
  • [22] Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
    Epstein, JI
    Chan, DW
    Sokoll, LJ
    Walsh, PC
    Cox, JL
    Rittenhouse, H
    Wolfert, R
    Carter, HB
    JOURNAL OF UROLOGY, 1998, 160 (06): : 2407 - 2411
  • [23] Change in prostate cancer grade over time in men followed expectantly for stage T1c disease - Comment
    Jarrard, David F.
    JOURNAL OF UROLOGY, 2008, 179 (03): : 904 - 905
  • [24] SYSTEMATIC PROSTATE BIOPSY WITH INSUFFICIENT BIOPSY CORE NUMBER AT DIAGNOSIS LEADS PSA FAILURE AFTER BRACHYTHERAPY AS MONOTHERAPY FOR CLINICAL STAGE T1C PROSTATE CANCER
    Ozawa, Yu
    Nohara, Sunao
    Nakamura, Ken
    Hattori, Seiya
    Yagi, Yasuto
    Nishiyama, Toru
    Yorozu, Atsunori
    Monma, Tetsuo
    Saito, Shiro
    JOURNAL OF UROLOGY, 2023, 209 : E420 - E420
  • [25] The impact of the biopsy gleason score on PSA outcome for prostate cancer patients with PSA≤10 ng/ml and T1C,2A:: Implications for patient selection for prostate-only therapy
    D'Amico, AV
    Renshaw, AA
    Schultz, D
    Rocha, S
    Richie, JP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04): : 847 - 851
  • [26] Predicting prostate specific antigen failure after radical retropubic prostatectomy for T1c prostate cancer
    Ou, YC
    Chen, JT
    Yang, CR
    Cheng, CL
    Ho, HC
    Ko, JL
    Hsieh, YS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (12) : 536 - 542
  • [27] Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer?
    Meng M.V.
    Carroll P.R.
    Current Urology Reports, 2001, 2 (3) : 237 - 241
  • [28] Preoperative PSA and progression-free survival after radical prostatectomy for stage T1c disease
    Antenor, JAV
    Roehl, KA
    Eggener, SE
    Kundu, SD
    Han, M
    Catalona, WJ
    UROLOGY, 2005, 66 (01) : 156 - 160
  • [29] Expectant management as an option for men with stage T1c prostate cancer: a preliminary study
    Mohler, JL
    Williams, BT
    Freeman, JA
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 364 - 368
  • [30] Expectant management as an option for men with stage T1c prostate cancer: a preliminary study
    James L. Mohler
    Bernadette T. Williams
    John A. Freeman
    J. L. Mohler
    World Journal of Urology, 1997, 15 : 364 - 368
12345